704 related articles for article (PubMed ID: 7563509)
21. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
22. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination.
Anderson S; Harper LM; Dionne-Odom J; Halle-Ekane G; Tita ATN
Int J Gynaecol Obstet; 2018 Apr; 141(1):126-132. PubMed ID: 29315536
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
[TBL] [Abstract][Full Text] [Related]
24. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.
Schillie S; Vellozzi C; Reingold A; Harris A; Haber P; Ward JW; Nelson NP
MMWR Recomm Rep; 2018 Jan; 67(1):1-31. PubMed ID: 29939980
[TBL] [Abstract][Full Text] [Related]
25. [Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection].
Shi G; Zhang SX
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):273-8. PubMed ID: 23759236
[TBL] [Abstract][Full Text] [Related]
26. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
[TBL] [Abstract][Full Text] [Related]
27. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
28. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
Holliday SM; Faulds D
Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
[TBL] [Abstract][Full Text] [Related]
30. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
32. Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data--United States.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(13):410-3. PubMed ID: 21471948
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies.
Wiebe T; Fergusson P; Horne D; Shanahan M; Macdonald A; Heise L; Roos LL
Med Decis Making; 1997; 17(4):472-82. PubMed ID: 9343806
[TBL] [Abstract][Full Text] [Related]
34. Implementing strategies for hepatitis B vaccination.
Alavian SM; Fallahian F; Lankarani KB
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):10-22. PubMed ID: 20061687
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
36. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
Szucs TD; Smala A; Berger K; Windorfer A
Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
[TBL] [Abstract][Full Text] [Related]
37. What is the best hepatitis B vaccination strategy for South Africa?
Karim SS
S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
[No Abstract] [Full Text] [Related]
38. Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree.
Yang N; Lei L; Meng Y; Zhou N; Shi L; Hu M
Front Public Health; 2022; 10():662442. PubMed ID: 35801242
[TBL] [Abstract][Full Text] [Related]
39. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
